Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 4Completed 3Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Ovarian Cancer Recurrent 1

Interventions

pembrolizumab 85Specimen Handling 79Carboplatin 73Magnetic Resonance Spectroscopy 71Biopsy 58Nivolumab 55Cisplatin 54Paclitaxel 46Cyclophosphamide 44durvalumab 37Radiotherapy 36Radiation 35olaparib 34Rituximab 34Etoposide 33Dexamethasone 33Ipilimumab 30Gemcitabine 30Lenalidomide 28Taxes 27Doxorubicin 27Docetaxel 27Pemetrexed 26Bevacizumab 24Prednisone 23Cytarabine 23X-Rays 22Trastuzumab 21cabozantinib 20Disulfides 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Has results × poly(I).poly(c12,U) × Clear all
NCT03734692 2026-02-12

Systemic Immune Checkpoint Blockade and Intraperitoneal Chemo-Immunotherapy in Recurrent Ovarian Cancer

University of Pittsburgh

Phase 1/2 Active not recruiting
24 enrolled 59 charts
Gynecologic

Ovarian Cancer Recurrent

Data powered by HemOnc (CC BY 4.0) Colophon âš¡